A systematic identification of multiple toxin-target interactions based on chemical, genomic and toxicological data

Wei Zhou1, Chao Huang, Yan Li

  • 1College of Life Science, Northwest A&F University, Yangling, Shaanxi 712100, China.

Toxicology
|January 15, 2013
PubMed

Insights

A new systems toxicology approach predicts toxin targets and networks using machine learning. This method enhances drug development and environmental risk assessment by analyzing complex biological data efficiently.

Area of Science:

  • Toxicology
  • Computational Biology
  • Bioinformatics

Background:

  • Experimental toxicity assessment is challenging and time-consuming.
  • Large amounts of -omics data (genomic, proteomic, metabolomic) are available but underutilized for toxicity prediction.
  • A need exists for efficient methods to predict molecular toxicity and mechanisms.

Purpose of the Study:

  • To develop a systems toxicology approach for predicting toxin targets and their associated networks.
  • To integrate diverse chemical, genomic, and toxicological data for improved predictions.
  • To validate in silico models using phenotypic disease classifications.

Main Methods:

  • Utilized Support Vector Machine (SVM) and Random Forest (RF) for predicting toxin-target interactions.
  • Extracted chemical and genomic features to build predictive models.
  • Constructed a genome-scale toxin-target-disease network, exemplified by cardiovascular disease.
  • Performed topological network analysis to identify critical targets and pathways.

Main Results:

  • Developed robust and reliable in silico models for predicting multiple toxin-target interactions.
  • Generated a genome-scale network revealing toxin-target-disease relationships.
  • Identified highly susceptible targets and critical toxins through network analysis.
  • Uncovered toxin-specific mechanisms and biological pathways.

Conclusions:

  • The presented systems toxicology methodology offers a more efficient, acceptable, and cost-effective approach.
  • This approach can significantly improve drug development processes.
  • Enhances the accuracy and efficiency of toxin environmental risk assessment.

Related Concept Videos

Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...